KIMBERLY FLOWERS: Open Payments
NPI 1366045924 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 23 payments from 8 companies in 2025. Trend: 2023 $443 · 2024 $2,214 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $213 |
| Novo Nordisk Inc | 2 | $142 |
| Tandem Diabetes Care, Inc. | 2 | $112 |
| Dexcom, Inc. | 2 | $109 |
| BETA BIONICS, INC. | 4 | $109 |
| Madrigal Pharmaceuticals | 1 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $91 |
| Corcept Therapeutics | 1 | $18 |
Products named: MINIMED 780G, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, iLet Bionic Pancreas, REZDIFFRA, TZIELD, Wegovy.
Industry payments across OR — which companies pay providers there.
